Marine Drugs (Feb 2020)

Characterization of a New Chitosanase from a Marine <i>Bacillus</i> sp. and the Anti-Oxidant Activity of Its Hydrolysate

  • Chunrui Ma,
  • Xiao Li,
  • Kun Yang,
  • Shangyong Li

DOI
https://doi.org/10.3390/md18020126
Journal volume & issue
Vol. 18, no. 2
p. 126

Abstract

Read online

Chitooligosaccharide (COS) has been recognized to exhibit efficient anti-oxidant activity. Enzymatic hydrolysis using chitosanases can retain all the amino and hydroxyl groups of chitosan, which are necessary for its activity. In this study, a new chitosanase encoding gene, csnQ, was cloned from the marine Bacillus sp. Q1098 and expressed in Escherichia coli. The recombinant chitosanase, CsnQ, showed maximal activity at pH 5.31 and 60 °C. Determination of CsnQ pH-stability showed that CsnQ could retain more than 50% of its activity over a wide pH, from 3.60 to 9.80. CsnQ is an endo-type chitosanase, yielding chitodisaccharide as the main product. Additionally, in vitro and in vivo analyses indicated that chitodisaccharide possesses much more effective anti-oxidant activity than glucosamine and low molecular weight chitosan (LMW-CS) (~5 kDa). Notably, to our knowledge, this is the first evidence that chitodisaccharide is the minimal COS fragment required for free radical scavenging.

Keywords